Download PDF
Allgemein- und Viszeralchirurgie up2date 2013; 7(6): 467-490
DOI: 10.1055/s-0033-1346903
Leber, Galle, Pankreas, Milz
Georg Thieme Verlag KG Stuttgart · New York

Portale Hypertension

N. Schäfer
1   Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und Gefäßchirurgie der Rheinischen Friedrich-Wilhelms-Universität Bonn
,
J. C. Kalff
1   Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und Gefäßchirurgie der Rheinischen Friedrich-Wilhelms-Universität Bonn
› Author Affiliations
Further Information

Publication History

Publication Date:
11 December 2013 (online)

Also available at
    Permissions and Reprints All articles of this category

Dieser Beitrag soll den aktuellen Stand des Wissens zur Pathophysiologie und Ätiologie der portalen Hypertension darstellen und einen sinnvollen Ansatz zur Patientenevaluation und zum diagnostischen Management vorschlagen. Des Weiteren sollen die wesentlichen primär- und sekundärprophylaktischen Therapiealgorithmen, insbesondere im Hinblick auf die viszeralmedizinisch interventionell und chirurgisch relevante Komplikation einer gastroösophagealen Varizenblutung, aufgezeigt werden.

 

  • Zum Weiterlesen und Vertiefen/Quellenangaben

  • Abu-Elmagd KM, Costa G, Bond GJ et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg 2009; 250: 567-581
    Google Scholar
  • Berzigotti A, Seijo S, Reverter E et al. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol 2013; 7: 141-155
    CrossrefGoogle Scholar
  • Boyer TD, Henderson JM, Heerey AM et al. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol 2008; 48: 407-414
    CrossrefGoogle Scholar
  • Clark W, Hernandez J, McKeon B et al. Surgical shunting versus transjugular intrahepatic portasystemic shunting for bleeding varices resulting from portal hypertension and cirrhosis: a meta-analysis. Am Surg 2010; 76: 857-864
    Google Scholar
  • Clark W, Golkar F, Luberice K et al. Uncovering the truth about covered stents: is there a difference between covered versus uncovered stents with transjugular intrahepatic portosystemic shunts?. Am J Surg 2011; 202: 561-564
    CrossrefPubMedGoogle Scholar
  • Costa G, Cruz jr. RJ, Abu-Elmagd KM. Surgical shunt versus TIPS for treatment of variceal hemorrhage in the current era of liver and multivisceral transplantation. Surg Clin North Am 2010; 90: 891-905
    CrossrefGoogle Scholar
  • de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-768
    CrossrefGoogle Scholar
  • Donadini MP, Dentali F, Ageno W. Splanchnic vein thrombosis: new risk factors and management. Thromb Res 2012; 129 (Suppl. 01) 93-96
    CrossrefGoogle Scholar
  • Galloway JR, Henderson JM. Management of variceal bleeding in patients with extrahepatic portal vein thrombosis. Am J Surg 1990; 160: 122-127
    CrossrefGoogle Scholar
  • Henderson JM, Boyer TD, Kutner MH et al. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 2006; 130: 1643-1651
    CrossrefPubMedGoogle Scholar
  • Hirner A, Weise K. Chirurgie. Schnitt für Schnitt. Stuttgart: Thieme; 2004: 526-537
    Article in Thieme ConnectGoogle Scholar
  • Horton JD, San Miguel FL, Membreno F et al. Budd-Chiari syndrome: illustrated review of current management. Liver Int 2008; 28: 455-466
    CrossrefGoogle Scholar
  • McMahon C, Abu-Elmagd K, Bontempo FA et al. JAK2 V617F mutation in patients with catastrophic intra-abdominal thromboses. Am J Clin Pathol 2007; 127: 736-743
    CrossrefGoogle Scholar
  • Primignani M. Portal vein thrombosis, revisited. Dig Liver Dis 2010; 42: 163-170
    CrossrefGoogle Scholar
  • Rosemurgy AS, Zervos EE. Management of variceal hemorrhage. Curr Probl Surg 2003; 40: 263-343
    Google Scholar
  • Rosemurgy AS, Bloomston M, Clark WC et al. H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals. Ann Surg 2005; 241: 238-246
    CrossrefPubMedGoogle Scholar
  • Rosemurgy AS, Frohman HA, Teta AF et al. Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial. J Am Coll Surg 2012; 214: 445-453
    CrossrefPubMedGoogle Scholar
  • Sauerbruch T, Appenrodt B, Schmitz V et al. The conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosis. Dtsch Arztebl Int 2013; 110: 126-132
    Google Scholar
  • Toomey PG, Ross SB, Golkar FC et al. Outcomes after transjugular intrahepatic portosystemic stent shunt: a “bridge” to nowhere. Am J Surg 2013; 205: 441-446
    CrossrefGoogle Scholar
  • Wolff M, Hirner A. [Surgical treatment of portal hypertension]. Zentralbl Chir 2005; 130: 238-245
    Article in Thieme ConnectGoogle Scholar